The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke--a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia.
Internal Medicine Journal · 2009-05-01 · Guideline / consensus
Abstract
Intravenous tissue plasminogen activator (tPA) has been licensed in Australia for thrombolysis in selected patients with acute ischaemic stroke since 2003. The use of tPA is low but is increasing across Australia and national audits indicate efficacy and safety outcomes equivalent to international benchmarks. Implementing tPA therapy in clinical practice is, however, challenging and requires a coordinated multidisciplinary approach to acute stroke care across prehospital, emergency department and inpatient care sectors. Stroke care units are an essential ingredient underpinning safe implementation of stroke thrombolysis. Support systems such as care pathways, therapy delivery protocols, and thrombolysis-experienced multidisciplinary care teams are also important enablers. Where delivery of stroke thrombolysis is being planned, health systems need to be re-configured to provide these important elements. This consensus statement provides a review of the evidence for, and implementation of, tPA in acute ischaemic stroke with specific reference to the Australian health-care system.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antithrombotics & thrombolytics · Implementation · Thrombolytics
Related articles
- Cluster-Randomized Trial of Thrombolysis Implementation Support in Metropolitan and Regional Australian Stroke Centers: Lessons for Individual and Systems Behavior Change. (J Am Heart Assoc, 2020)
- Economic Evaluation of a Pre-Hospital Protocol for Patients with Suspected Acute Stroke. (Front Public Health, 2018)
- Improving access to acute stroke therapies: a controlled trial of organised pre-hospital and emergency care. (Med J Aust, 2008)
- From guidelines to clinical practice in care for ischaemic stroke patients: A systematic review and expert opinion. (Eur J Neurol, 2024)
- Stroke 20 20: Implementation goals for intravenous thrombolysis. (Eur Stroke J, 2021)
- How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care. (Implement Sci, 2016)